|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | |
| C07K 14/54 | |||
| C07K 16/24 |
| (11) | Number of the document | 2427203 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10739395.1 |
| Date of filing the European patent application | 2010-05-05 | |
| (97) | Date of publication of the European application | 2012-03-14 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2010/001436 |
| Date | 2010-05-05 |
| (87) | Number | WO 2010/128407 |
| Date | 2010-11-11 |
| (30) | Number | Date | Country code |
| 175512 P | 2009-05-05 | US |
| (72) |
MASTERNAK, Krzysztof, CH
ROUSSEAU, Francois, FR
|
| (73) |
Novimmune S.A.,
14 Ch. Des Aulx Plan-Les Aulx Plan-les-Ouates, 1228 Geneva,
CH
|
| (54) | ANTI-IL-17F ANTIBODIES AND USE THEREOF |
| ANTI-IL-17F ANTIBODIES AND USE THEREOF |